These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38446441)

  • 1. Adaptive selection of the optimal strategy to improve precision and power in randomized trials.
    Balzer LB; Cai E; Godoy Garraza L; Amaranath P
    Biometrics; 2024 Jan; 80(1):. PubMed ID: 38446441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive pre-specification in randomized trials with and without pair-matching.
    Balzer LB; van der Laan MJ; Petersen ML;
    Stat Med; 2016 Nov; 35(25):4528-4545. PubMed ID: 27436797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving precision and power in randomized trials for COVID-19 treatments using covariate adjustment, for binary, ordinal, and time-to-event outcomes.
    Benkeser D; Díaz I; Luedtke A; Segal J; Scharfstein D; Rosenblum M
    Biometrics; 2021 Dec; 77(4):1467-1481. PubMed ID: 32978962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating tests for cluster-randomized trials with few clusters under generalized linear mixed models with covariate adjustment: A simulation study.
    Qiu H; Cook AJ; Bobb JF
    Stat Med; 2024 Jan; 43(2):201-215. PubMed ID: 37933766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mind the gap: covariate constrained randomisation can protect against substantial power loss in parallel cluster randomised trials.
    Kristunas C; Grayling M; Gray LJ; Hemming K
    BMC Med Res Methodol; 2022 Apr; 22(1):111. PubMed ID: 35413793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials?
    Karrison T; Kocherginsky M
    Clin Trials; 2018 Apr; 15(2):178-188. PubMed ID: 29502444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of covariate adjustment approaches under model misspecification in individually randomized trials.
    Tackney MS; Morris T; White I; Leyrat C; Diaz-Ordaz K; Williamson E
    Trials; 2023 Jan; 24(1):14. PubMed ID: 36609282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing for treatment effect in covariate-adaptive randomized trials with generalized linear models and omitted covariates.
    Li Y; Ma W; Qin Y; Hu F
    Stat Methods Med Res; 2021 Sep; 30(9):2148-2164. PubMed ID: 33899607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving precision and power in randomized trials with a two-stage study design: Stratification using clustering method.
    Ye X; Lu N; Xu Y
    Pharm Stat; 2023 Mar; 22(2):396-407. PubMed ID: 36504179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Precision and Power in Randomized Trials for COVID-19 Treatments Using Covariate Adjustment, for Binary, Ordinal, and Time-to-Event Outcomes.
    Benkeser D; Díaz I; Luedtke A; Segal J; Scharfstein D; Rosenblum M
    medRxiv; 2020 Jun; ():. PubMed ID: 32577668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive pair-matching in randomized trials with unbiased and efficient effect estimation.
    Balzer LB; Petersen ML; van der Laan MJ;
    Stat Med; 2015 Mar; 34(6):999-1011. PubMed ID: 25421503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-Stage TMLE to reduce bias and improve efficiency in cluster randomized trials.
    Balzer LB; van der Laan M; Ayieko J; Kamya M; Chamie G; Schwab J; Havlir DV; Petersen ML
    Biostatistics; 2023 Apr; 24(2):502-517. PubMed ID: 34939083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covariate adjustment in randomized controlled trials: General concepts and practical considerations.
    Van Lancker K; Bretz F; Dukes O
    Clin Trials; 2024 Aug; 21(4):399-411. PubMed ID: 38825841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The benefits of covariate adjustment for adaptive multi-arm designs.
    Lee KM; Robertson DS; Jaki T; Emsley R
    Stat Methods Med Res; 2022 Nov; 31(11):2104-2121. PubMed ID: 35876412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covariate adjustment in Bayesian adaptive randomized controlled trials.
    Willard J; Golchi S; Moodie EE
    Stat Methods Med Res; 2024 Mar; 33(3):480-497. PubMed ID: 38327082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Super-covariates": Using predicted control group outcome as a covariate in randomized clinical trials.
    Holzhauer B; Adewuyi ET
    Pharm Stat; 2023; 22(6):1062-1075. PubMed ID: 37553959
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.